Published in Law and Health Weekly, January 27th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Nektar Therapeutics.
Report 1: Nektar Therapeutics (NKTR) announced its financial results for the past three months with total revenue of $58.6 million compared to $36.4 million for the three months in 2005.
For the three months product sales and royalty revenue were $41.5 million compared to $8.5 million in the three months in 2005, and contract revenue totaled $15.1 million compared to $23.7 million in the three months in 2005. Exubera product and royalty revenue...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly